Emma Cotton
Medical · Brockton, MANPI 1851918916
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 250 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 23.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,670 and has fallen 52.5% since, to $793 in 2025. Among medical clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 250 payments — averaging $21.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- Astellas Pharma US Inc$557
- Pfizer$529
- Dentsply IH AB$433
- Myovant Sciences Inc.$408
- Sumitomo Pharma America, Inc.$386
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,23595%
- Education$2555%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 69 | $1,266 |
| Astellas Pharma US Inc | 18 | $557 |
| Pfizer | 23 | $529 |
| Dentsply IH AB | 16 | $433 |
| Myovant Sciences Inc. | 15 | $408 |
| Sumitomo Pharma America, Inc. | 18 | $386 |
| Mayne Pharma Commercial LLC | 15 | $223 |
| Ardelyx, Inc. | 10 | $211 |
| AbbVie | 6 | $165 |
| Urovant Sciences Inc | 10 | $151 |
| Vertex | 5 | $148 |
| Daiichi Sankyo Inc. | 7 | $148 |
| Shield Therapeutics Inc | 6 | $117 |
| Sage Therapeutics, LLC | 4 | $99 |
| Aspira Women's Health Inc | 1 | $94 |
| Boston Scientific | 2 | $75 |
| Exact Sciences | 3 | $72 |
| Evofem Biosciences, Inc. | 4 | $70 |
| Axonics, Inc. | 3 | $65 |
| Agile Therapeutics, Inc. | 3 | $61 |
| Exeltis, USA Inc. | 3 | $55 |
| Therapeuticsmd, Inc. | 2 | $36 |
| Novo Nordisk | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Bayer | 1 | $22 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
| Azurity Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MYFEMBREE$109
How this compares
$5,490 in reported general payments places this provider in the 95th percentile of 421 medical providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EstringEstradiol | 73 | $38,288 |
| IbsrelaTenapanor Hcl | 15 | $37,350 |
| PremarinEstrogens, Conjugated | 54 | $25,045 |
| Estradiol | 223 | $14,797 |
| GemtesaVibegron | 15 | $12,565 |
| MyrbetriqMirabegron | 21 | $10,779 |
| Estradiol (Once Weekly)Estradiol | 31 | $3,409 |
| Estradiol (Twice Weekly)Estradiol | 15 | $1,596 |
| Fosfomycin Tromethamine | 12 | $1,241 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 39 | $369 |
| Metronidazole | 26 | $354 |
| Triamcinolone Acetonide | 55 | $272 |
| Levothyroxine Sodium | 15 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $161 |
| Ciprofloxacin Hcl | 37 | $132 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEstring, Premarin | $529 | $63,333127 claims |
| Ardelyx, Inc.Ibsrela | $211 | $37,35015 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $386 | $12,56515 claims |
| Astellas Pharma US IncMyrbetriq | $557 | $10,77921 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 421 medical providers in Massachusetts.
Other medical in Brockton
- Eileen CheeverLeominster$389K
- Vidal PrimiterioLawrence$22K
- Michelle BaytarianJamaica Plain$17K
- Julia FioreAgawam$16K
- Jennifer LevesqueFall River$15K
- Ashley HoffmanWestfield$13K
- Theresa FukudaBoston$13K
- Christina MessingerPlymouth$11K
- Lauren CarraSpringfield$9K
- Raul AliceaSpringfield$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.